Project 3
HER2-positive advanced solid tumors
Phase IActive
Key Facts
About Suzhou Teligene
Clinical-stage Chinese biotech developing brain-penetrant small molecule targeted therapies for oncology, with multiple programs in Phase I-II trials.
View full company profileTherapeutic Areas
Other HER2-positive advanced solid tumors Drugs
| Drug | Company | Phase |
|---|---|---|
| Project 7 | Suzhou Teligene | IND Submitted |